Table 1.

Clinical Characteristics and Hormonal Parameters of the Study Population

	Healthy subjects (n=17)	PCOS (n=18)	PCOS during metformin (n=18)
Age, years	20±1	18±1	18±1
SBPa, mmHg	112.7±6.7	123.1±10.0*	116.1±9.1†
DBPb, mmHg	67.0±4.9	75.6±8.8*	70.9±8.7†
BMIc, Kg/m2	22.5±1.5	26.8±6.3*	25.8±5.6
Androstenedione, ng/dL	2.0±0.7	3.33±0.7**	2.7±0.3†
TotalTestosterone, ng/dL	60.1±11	123.1±12 **	84.7±19†
SHBGd, nmol/L	26.4±4.4	20.3±8.3**	24.7±9.8†
DHEASe, μg/dL	142±34	321±90**	267±58†
FAIf, %	2.4±0.9	9.3±3.2**	4.1±1.8†

Data are presented as the mean ± SD or number of subjects.

^asystolic blood pressure;

^bdiastolic blood pressure;

^cbody mass index;

^dsex hormone-binding globulin;

^edehydroepiandrosterone sulfate;

^ffree androgen index;

^*p<0.01 vs. healthy subjects;

^**p<0.001 vs. healthy subjects,

^†p<0.05 vs PCOS patients at baseline.